Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men

Osteoporosis International

Volumn 20, Issue 7, 2009, Pages 1167-1173

  Marsell, R ^a   Mirza, M A I ^a   Mallmin, H ^a   Karlsson, M ^b   Mellstrom D ^c   Orwoll, E ^d   Ohlsson, C ^c   Jonsson, K B ^a   Ljunggren, O ^a   Larsson, T E ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

BMD; Bone densitometry; Bone mineralization; FGF 23; Fibroblast growth factor 23; Growth factors

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ELDERLY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR HEAD; FEMUR NECK; GENE OVEREXPRESSION; HIP; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RICKETS; SMOKING; SWEDEN; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BODY WEIGHT; BONE DENSITY; FEMUR; FEMUR NECK; FIBROBLAST GROWTH FACTORS; HUMANS; LUMBAR VERTEBRAE; MALE; PROSPECTIVE STUDIES; SWEDEN;

EID: 67349176732     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0780-2     Document Type: Article

References (24)

1. T Shimada S Mizutani T Muto T Yoneya R Hino S Takeda Y Takeuchi T Fujita S Fukumoto T Yamashita 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proc Natl Acad Sci USA 98 11 6500 6505 (Pubitemid 32488266)
2. EA Imel MJ Econs 2007 Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23 Pediatr Endocrinol Rev 4 Suppl 4 434 439 (Pubitemid 47546983)
3. T Larsson X Yu SI Davis MS Draman SD Mooney MJ Cullen KE White 2005 novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis J Clin Endocrinol Metab 90 4 2424 2427 (Pubitemid 40586293)
4. T Larsson U Nisbeth O Ljunggren H Juppner KB Jonsson 2003 Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney Int 64 6 2272 2279 (Pubitemid 37449564)
5. A Gupta K Winer MJ Econs SJ Marx MT Collins 2004 FGF-23 is elevated by chronic hyperphosphatemia J Clin Endocrinol Metab 89 9 4489 4492 (Pubitemid 39244460)
6. M Riminucci MT Collins NS Fedarko N Cherman A Corsi KE White S Waguespack A Gupta T Hannon MJ Econs P Bianco P Gehron Robey 2003 FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting J Clin Invest 112 5 683 692 (Pubitemid 38057709)
7. S Liu R Guo LG Simpson ZS Xiao CE Burnham LD Quarles 2003 Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX J Biol Chem 278 39 37419 37426 (Pubitemid 37175262)
8. T Shimada M Kakitani Y Yamazaki H Hasegawa Y Takeuchi T Fujita S Fukumoto K Tomizuka T Yamashita 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 4 561 568 (Pubitemid 38542505)
9. M Ito Y Sakai M Furumoto H Segawa S Haito S Yamanaka R Nakamura M Kuwahata K Miyamoto 2005 Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells Am J Physiol Endocrinol Metab 288 6 E1101 E1109
10. T Larsson R Marsell E Schipani C Ohlsson O Ljunggren HS Tenenhouse H Juppner KB Jonsson 2004 Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis Endocrinology 145 7 3087 3094 (Pubitemid 38829975)
11. I Urakawa Y Yamazaki T Shimada K Iijima H Hasegawa K Okawa T Fujita S Fukumoto T Yamashita 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23 Nature 444 7120 770 774 (Pubitemid 44949607)
12. Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23(6):939-948 Jun (Pubitemid 351768812)
13. M Kuro-o Y Matsumura H Aizawa H Kawaguchi T Suga T Utsugi Y Ohyama M Kurabayashi T Kaname E Kume H Iwasaki A Iida T Shiraki-Iida S Nishikawa R Nagai YI Nabeshima 1997 Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 6655 45 51 (Pubitemid 27494749)
14. KE White TM Larsson MJ Econs 2006 The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: Frp-4, MEPE, and FGF23 Endocr Rev 27 3 221 241
15. D Mellstrom O Johnell O Ljunggren AL Eriksson M Lorentzon H Mallmin A Holmberg I Redlund-Johnell E Orwoll C Ohlsson 2006 Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden J Bone Miner Res 21 4 529 535
16. Y Lu T Fuerst S Hui HK Genant 2001 Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle Osteoporos Int 12 6 438 444 (Pubitemid 32607085)
17. HK Genant S Grampp CC Gluer KG Faulkner M Jergas K Engelke S Hagiwara C Van Kuijk 1994 Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results J Bone Miner Res 9 10 1503 1514 (Pubitemid 24300099)
18. J Hanson 1997 Standardization of proximal femur BMD measurements. International Committee for Standards in Bone Measurement Osteoporos Int 7 5 500 501
19. Y Yamazaki R Okazaki M Shibata Y Hasegawa K Satoh T Tajima Y Takeuchi T Fujita K Nakahara T Yamashita S Fukumoto 2002 Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia J Clin Endocrinol Metab 87 11 4957 4960 (Pubitemid 35316332)
20. R Marsell E Grundberg T Krajisnik H Mallmin M Karlsson D Mellstrom E Orwoll C Ohlsson KB Jonsson O Ljunggren TE Larsson 2008 Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men Eur J Endocrinol 158 1 125 129 (Pubitemid 351211049)
21. M Flodin AS Jonsson LO Hansson LA Danielsson A Larsson 2007 Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L Scand J Clin Lab Invest 67 5 560 567 (Pubitemid 47344352)
22. KB Jonsson R Zahradnik T Larsson KE White T Sugimoto Y Imanishi T Yamamoto G Hampson H Koshiyama O Ljunggren K Oba IM Yang A Miyauchi MJ Econs J Lavigne H Juppner 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia N Engl J Med 348 17 1656 1663 (Pubitemid 36459471)
23. P Urena Torres G Friedlander MC de Vernejoul C Silve D Prie 2008 Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients Kidney Int 73 1 102 107 (Pubitemid 350273643)
24. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G (2006) Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116(12):3150-3159 Dec (Pubitemid 44878629)